Short Bowel Syndrome (SBS) is a devastating clinical disorder that has a high prevalence of mortality and morbidity and takes a severe socioeconomic toll on patients. The hallmark of SBS is poor absorption of fluid and vital nutrients due to insufficient function or lack of large portions of the small intestine. Surgical and pharmacological means to enhance or grow the remaining intestinal tissue have thus far not been successful. In the U.S., the annual prevalence of patients requiring TPN due to SBS is approximately 12,000 per year. The annual cost of TPN is over $100,000 per year per patient. One potential long term treatment for SBS would be the development of a living, tissue engineered small intestinal graft to replace the lost tissue. The goal of this renewal grant is to use our existing biodegradable and biocompatible elastomers that can be tailored for specific soft tissue applications, to develop new approaches for treating intestinal defects. Previous scaffolds have not provided sufficient structural guidance to promote the regeneration of a fully biomimetic small intestinal tissue. A major limitation of previous approaches has been the lack of proper smooth muscle formation and intestinal motility and there has been a lack of morphological guidance to generate biomimetic tissue structures. In particular, given the unique multi-laminar and hierarchically-structured nature of small intestine, one promising new approach would be to microfabricate scaffolds from soft bioresorbable elastomers. We believe that these materials can be harnessed via microfabrication to create an in vitro model of small intestinal tissue that may also serve as a functional tissue engineered intestine, and a useful in vitro model for testing new drugs and other agents. Our overall hypothesis is that functional tissue engineering of small intestine requires microfabricated elastomeric scaffolds capable of guiding the formation of the mucosa and muscle layers and respective nutrient transport and peristalsis functions.
We aim to: 1. Develop microfabricated elastomeric scaffolds for functional maturation of the mucosa layer of tissue engineered small intestine. 2. Investigate the use of microfabricated elastomeric scaffolds for functional maturation of the muscular is propria layer of tissue engineered small intestine. 3. Develop patches and tubes of microfabricated elastomeric scaffolds for functional maturation of mucosa and muscular is propria layers of tissue engineered small intestine and test in vivo.
The goal of this renewal grant is to use our existing biodegradable and biocompatible elastomers that can be tailored for specific soft tissue applications, to develop new approaches for treating intestinal defects. We will address the overall hypothesis that functional tissue engineering of biomimetic small intestine requires microfabricated elastomeric scaffolds capable of guiding the formation of the mucosa and muscular is propria layers.
|Tong, Zhixiang; Martyn, Keir; Yang, Andy et al. (2018) Towards a defined ECM and small molecule based monolayer culture system for the expansion of mouse and human intestinal stem cells. Biomaterials 154:60-73|
|Mead, Benjamin E; Ordovas-Montanes, Jose; Braun, Alexandra P et al. (2018) Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types. BMC Biol 16:62|
|McLean, Will J; Yin, Xiaolei; Lu, Lin et al. (2017) Clonal Expansion of Lgr5-Positive Cells from Mammalian Cochlea and High-Purity Generation of Sensory Hair Cells. Cell Rep 18:1917-1929|
|Doloff, Joshua C; Veiseh, Omid; Vegas, Arturo J et al. (2017) Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates. Nat Mater 16:671-680|
|Jhunjhunwala, Siddharth; Alvarez, David; Aresta-DaSilva, Stephanie et al. (2016) Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation. J Leukoc Biol 100:253-60|
|Lim, Dong-Kwon; Wylie, Ryan G; Langer, Robert et al. (2016) Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF(165). Biomaterials 77:130-138|
|Vegas, Arturo J; Veiseh, Omid; Gürtler, Mads et al. (2016) Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med 22:306-11|
|Vegas, Arturo J; Veiseh, Omid; Doloff, Joshua C et al. (2016) Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 34:345-52|
|Langer, Robert; Vacanti, Joseph (2016) Advances in tissue engineering. J Pediatr Surg 51:8-12|
|Yin, Xiaolei; Mead, Benjamin E; Safaee, Helia et al. (2016) Engineering Stem Cell Organoids. Cell Stem Cell 18:25-38|
Showing the most recent 10 out of 76 publications